Effekt av melatonin som hypnotikum vid sömnsvårigheter hos barn

 It is estimated that 25 % of children suffer from sleeping disorders. This is worrying as sleep is essential for children's health and is required for normal development of both body and brain. When changes in sleep hygiene are not sufficient to improve sleep, there is a need for pharmacologic...

Full description

Bibliographic Details
Main Author: Reineborn, Annefrid
Format: Others
Language:Swedish
Published: Linnéuniversitetet, Institutionen för kemi och biomedicin (KOB) 2017
Subjects:
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-62004
id ndltd-UPSALLA1-oai-DiVA.org-lnu-62004
record_format oai_dc
spelling ndltd-UPSALLA1-oai-DiVA.org-lnu-620042017-04-01T05:39:14ZEffekt av melatonin som hypnotikum vid sömnsvårigheter hos barnsweReineborn, AnnefridLinnéuniversitetet, Institutionen för kemi och biomedicin (KOB)2017melatoninsömnsvårighetersömnbesvärsömnstörningarbarnsömnhypnotikumsömnmedicinsömnläkemedelMedical and Health SciencesMedicin och hälsovetenskap It is estimated that 25 % of children suffer from sleeping disorders. This is worrying as sleep is essential for children's health and is required for normal development of both body and brain. When changes in sleep hygiene are not sufficient to improve sleep, there is a need for pharmacological options. One of those is to use the endogenous substance melatonin, which for instance controls the body's sleep/wake phases. In Sweden the use of exogenous melatonin as a hypnotic for children has increased significantly in recent years. The aim of this study was to examine the existing evidence for the use of melatonin in children with sleeping disorders.  In this literature review clinical studies, in which melatonin's efficacy in children with sleeping disorders is evaluated, have been analyzed. The studies were found by searching the data base PubMed.  Earlier sleep onset, shortened sleep onset latency, extended total sleep time and an earlier DLMO (dim light melatonin onset, the time when plasma melatonin levels reaches 10 pg/ml) were endpoints used in the majority of the studies. Most of the results for these sleep-specific parameters show a statistically significant improvement in melatonin treated subjects compared with placebo treatment. This is also confirmed by results from questionnaires. No dose-response relationship was found from analysis of the studies. Overall, the results show that melatonin has a good effect on sleeping disorders and that adverse effects that occur are mild.  The conclusion is that there is strong evidence for the use of melatonin for sleepingdisorders in children and that the increased use of melatonin can be motivated by this. Student thesisinfo:eu-repo/semantics/bachelorThesistexthttp://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-62004application/pdfinfo:eu-repo/semantics/openAccess
collection NDLTD
language Swedish
format Others
sources NDLTD
topic melatonin
sömnsvårigheter
sömnbesvär
sömnstörningar
barn
sömn
hypnotikum
sömnmedicin
sömnläkemedel
Medical and Health Sciences
Medicin och hälsovetenskap
spellingShingle melatonin
sömnsvårigheter
sömnbesvär
sömnstörningar
barn
sömn
hypnotikum
sömnmedicin
sömnläkemedel
Medical and Health Sciences
Medicin och hälsovetenskap
Reineborn, Annefrid
Effekt av melatonin som hypnotikum vid sömnsvårigheter hos barn
description  It is estimated that 25 % of children suffer from sleeping disorders. This is worrying as sleep is essential for children's health and is required for normal development of both body and brain. When changes in sleep hygiene are not sufficient to improve sleep, there is a need for pharmacological options. One of those is to use the endogenous substance melatonin, which for instance controls the body's sleep/wake phases. In Sweden the use of exogenous melatonin as a hypnotic for children has increased significantly in recent years. The aim of this study was to examine the existing evidence for the use of melatonin in children with sleeping disorders.  In this literature review clinical studies, in which melatonin's efficacy in children with sleeping disorders is evaluated, have been analyzed. The studies were found by searching the data base PubMed.  Earlier sleep onset, shortened sleep onset latency, extended total sleep time and an earlier DLMO (dim light melatonin onset, the time when plasma melatonin levels reaches 10 pg/ml) were endpoints used in the majority of the studies. Most of the results for these sleep-specific parameters show a statistically significant improvement in melatonin treated subjects compared with placebo treatment. This is also confirmed by results from questionnaires. No dose-response relationship was found from analysis of the studies. Overall, the results show that melatonin has a good effect on sleeping disorders and that adverse effects that occur are mild.  The conclusion is that there is strong evidence for the use of melatonin for sleepingdisorders in children and that the increased use of melatonin can be motivated by this.
author Reineborn, Annefrid
author_facet Reineborn, Annefrid
author_sort Reineborn, Annefrid
title Effekt av melatonin som hypnotikum vid sömnsvårigheter hos barn
title_short Effekt av melatonin som hypnotikum vid sömnsvårigheter hos barn
title_full Effekt av melatonin som hypnotikum vid sömnsvårigheter hos barn
title_fullStr Effekt av melatonin som hypnotikum vid sömnsvårigheter hos barn
title_full_unstemmed Effekt av melatonin som hypnotikum vid sömnsvårigheter hos barn
title_sort effekt av melatonin som hypnotikum vid sömnsvårigheter hos barn
publisher Linnéuniversitetet, Institutionen för kemi och biomedicin (KOB)
publishDate 2017
url http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-62004
work_keys_str_mv AT reinebornannefrid effektavmelatoninsomhypnotikumvidsomnsvarigheterhosbarn
_version_ 1718435944986574848